Press Release: Addex Reports Q3 2020 Financial -2-

Company's clinical candidate selection, clinical trials and the

reporting of data therefrom. These forward-looking statements are not

historical facts but rather are based on the Company's current

expectations, estimates, and projections about its industry; its

beliefs; and assumptions. Words such as 'anticipates,' 'expects,'

'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar

expressions are intended to identify forward-looking statements. These

statements are not guarantees of future performance and are subject to

known and unknown risks, uncertainties, and other factors, some of which

are beyond the Company's control, are difficult to predict, and could

cause actual results to differ materially from those expressed or

forecasted in the forward-looking statements, including delays resulting

from the COVID-19 pandemic and healthcare regulatory considerations. The

Company cautions securityholders and prospective securityholders not to

place undue reliance on these forward-looking statements, which reflect

the view of the Company only as of the date of this announcement. The

forward-looking statements made in this announcement relate only to

events as of the date on which the statements are made. The Company will

not undertake any obligation to release publicly any revisions or

updates to these forward-looking statements to reflect events,

circumstances, or unanticipated events occurring after the date of this

announcement except as required by law or by any appropriate regulatory

authority.

(END) Dow Jones Newswires

November 03, 2020 01:00 ET (06:00 GMT)